Pharmanutra S.p.A.

Milan Stock Exchange:PHN.MI

Sector

🏥 Health Care

Industries

💊 Pharmaceuticals

🏬 Consumer Packaged Goods

💊 Drugstores & Retail Pharmacies

🛍 Retail & Wholesale

🛍 Specialty Retail

Location

Italy

Market Cap

USD 546.52 M

Share Price

USD 55.02

Avg Daily Volume

9,931

Change (1 day)

-0.14%

Change (1 year)

11.64%

Change (YTD)

-2.80%

Pharmanutra S.p.A. Price to Earnings Ratio (P/E) on June 16, 2025: 31.78

Pharmanutra S.p.A. Price to Earnings Ratio (P/E) is 31.78 on June 16, 2025, a -5.54% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.

Pharmanutra S.p.A. 52-week low Price to Earnings Ratio (P/E) is 45.50 on June 16, 2025, which is 43.17% above the current Price to Earnings Ratio (P/E).
Pharmanutra S.p.A. 52-week low Price to Earnings Ratio (P/E) is 28.66 on June 16, 2025, which is -9.81% below the current Price to Earnings Ratio (P/E).
Pharmanutra S.p.A. average Price to Earnings Ratio (P/E) for the last 52 weeks is 37.13.

Daily

From:

To:

Zoom:

Key data

Date	Price to Earnings Ratio (P/E)	Price to Book Ratio (P/B)	Price to Sales Ratio (P/S)	Enterprise Value to EBITDA (EV/EBITDA)

Milan Stock Exchange: PHN.MI

Pharmanutra S.p.A.

CEO	Mr. Andrea Lacorte
IPO Date	July 18, 2017
Location	Italy
Headquarters	Via delle Lenze 216/B
Employees	118
Sector	🏥 Health Care
Industries Pharmaceuticals 🏬 Consumer Packaged Goods 💊 Drugstores & Retail Pharmacies 🛍 Retail & Wholesale 🛍 Specialty Retail

Description

Pharmanutra S.p.A., a pharmaceutical and nutraceutical company, researches, designs, develops, and markets nutritional supplements and medical devices in Italy, rest of Europe, the Middle East, Far East, and internationally. The company also produces and markets pharmaceuticals, medical devices, OTC products, and nutraceuticals for pediatric sector; and produces and distributes raw materials and active ingredients for the food, pharmaceutical, and food supplement industries. Its products primarily include SiderAL, SiderAL Forte, SiderAL Folic, Cardio SiderAL, SiderAL Med, Cetilar Crema, Cetilar Patch, Tape, ApportAL, UltraMag, Gestalys DHA, Novomega, Bonecal, and DiKappa 2. The company distributes and sells its products through sales representatives, wholesalers, pharmacies, and para-pharmacies. Pharmanutra S.p.A. was founded in 2003 and is based in Pisa, Italy.